Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.69, No.3, p.504–515, 2022 |
||
Title: Drug therapy for bone metastasis of malignant tumor: theory, progress, and potential | ||
Author: Ji-Zheng Tian, Ni-Na Ma, Xiao Li, Kun Shang, Bang-Wei Cao | ||
Abstract: Bone is a common metastatic site of malignancies, caused by the complex interaction between tumor cells and the bone microenvironment. The complicated procedure covers multiple targets for therapeutic strategies against bone metastasis. At the present, only bisphosphonates and denosumab are currently approved for the prevention of skeletal-related events. But it is still ineffective for some patients, and none of them are proven to prolong the overall survival of patients with bone metastasis. Thus, new bone-modifying agents and therapeutic strategies are required. The review aimed to generalize the basic theory of bone metastasis and major put emphasis on the development of fundamental and potential target drugs in the behavior of bone metastasis. The summary of the drug development process helps to provide ideas for finding new and effective treatments for bone metastasis. |
||
Keywords: bone metastasis; bone microenvironment; bone-modifying agents; skeletal-related events | ||
Published online: 01-Feb-2022 | ||
Year: 2022, Volume: 69, Issue: 3 | Page From: 504, Page To: 515 | |
doi:10.4149/neo_2021_211006N1412 |
||
|
download file |
|